Adial Pharmaceuticals, Inc. Excess Stock, Shares Issued
Adial Pharmaceuticals, Inc. (ADIL) had Excess Stock, Shares Issued of 8.00 thousand shares as of 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:ExcessStockSharesIssued · last filed 2024-04-01
- 2022-12-31: Excess Stock, Shares Issued 8.00K shares.
- 2022-06-30: Excess Stock, Shares Issued 270.00K shares.
| Period end | Excess Stock, Shares Issued |
|---|---|
| 2022-12-31 | 8.00K shares 10-K · filed 2024-04-01 |
| 2022-06-30 | 270.00K shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |